Board meeting to approve second-quarter and half-year results

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹0.45

prior close

₹0.44

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-0.4% vs market

Biotechnology peers, median of 5sector+1.8%-1.8% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 1.8 pts less than its Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.3

10m

+2.3

15m

+2.3

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0+0.4-0.4+1.8-1.8

Next day

+2.2+2.1+0.1+4.4-2.2

+2.2pendingpending+5.0-2.7

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Biotechnology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The company informed the stock exchanges that its Board will meet on Monday, November 2, 2026, to approve the unaudited financial results for the second quarter and half-year ended September 30, 2026. The Board may also address other business with its permission. No results, figures, or operating updates were provided.

Likely market impact

There is no immediate earnings information in this notice. Shareholders should wait for the results and Board decisions on November 2, 2026, which could influence the stock.